Schedule 13G ownership disclosure
Krystal Biotech Inc
Security class unavailable · CUSIP: 501147102
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,869,136
- Percent of class
- 10.0500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-078880
- Form type
- SC 13G
- Filer
- Krystal Biotech, Inc.
- CIK
- CIK 1711279
- Filed
- Jul 10, 2024
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership